News Feature Channel: AIDS and HIV

Ochsner Transplant Institute Among Site Collaborators in New England Journal of Medicine HIV-to-HIV Kidney Transplant Study

Ochsner Health — Mon, 11 Nov 2024 12:35:58 EST

The article, Safety of Kidney Transplantation from Donors with HIV, details findings supporting HIV-to-HIV kidney transplants as safe and just as effective as those using organs from donors without HIV.

A Gut Feeling About HIV and Heart Disease

Cedars-Sinai — Thu, 07 Nov 2024 10:20:15 EST

Ivan Vujkovic-Cvijin, PhD, is a pioneer in the study of the gut microbiota and the surprising ways these microorganisms living in our digestive tracts affect our overall health. His discoveries have been featured in Nature, Science Translational Medicine, Cell Reports and other top scientific journals.

Survey Finds Continued Declines in HIV Clinician Workforce

Wolters Kluwer Health: Lippincott — Mon, 04 Nov 2024 12:30:18 EST

The supply of healthcare professionals available to provide HIV care continues to decline, even as the need for HIV care and prevention is expected to increase, reports a survey study in the November/December issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Advanced Modeling Contributes to Progress in Thwarting HIV in Sweden

Los Alamos National Laboratory — Wed, 30 Oct 2024 12:10:32 EST

In a landmark achievement for the fight against HIV, Sweden has attained the critical "95-95-95" target on the path to tackling the disease. Advanced bioinformatics modeling developed by a team from Los Alamos National Laboratory was deployed to track and verify the country's progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization target.

Study Finds HIV-To-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs From Donors Without HIV

Johns Hopkins Medicine — Wed, 16 Oct 2024 17:15:29 EST

According to findings from a multicenter study led by Johns Hopkins Medicine and released today in The New England Journal of Medicine (NEJM), transplanting kidneys from deceased donors who had the human immunodeficiency virus (HIV) to recipients with HIV is safe. Perhaps more importantly, the study authors also found that HIV-to-HIV kidney transplants are comparable in effectiveness to those using organs from donors without HIV.

Mount Sinai Doctors to Present at ID Week 2024

Mount Sinai Health System — Wed, 16 Oct 2024 03:05:00 EST

Experts in infection prevention and control available for interview about research findings and other breaking health topics including the flu, COVID, HIV, mpox, West Nile, and vaccinations

Se Necesitan Urgentemente Nuevos Enfoques Para Erradicar La Crisis Del Vih/Sida en La PoblacioN Latina

Johns Hopkins School of Nursing — Wed, 09 Oct 2024 17:00:00 EST

En un nuevo articulo de investigacion publicado {hoy/esta semana} en la revista medica New England Journal of Medicine, los expertos en el tema recomiendan encarecidamente que todos los sectores de la comunidad de atencion de la salud actualicen sus enfoques para poder enfrentar la crisis permanente del VIH/SIDA en la poblacion latina. Este llamado a la accion surge en un momento en el que se refleja un progreso general en el esfuerzo realizado por varias decadas para erradicar la epidemia en los Estados Unidos.

Urgent New Approaches Needed to End HIV/AIDS Crisis Among Latinos

Johns Hopkins School of Nursing — Wed, 09 Oct 2024 17:00:00 EST

In a new paper published on October 9 in the New England Journal of Medicine, experts are urging all sectors of the health care community to urgently evolve their approaches to meet the continuing HIV/AIDS crisis among Latinos. This call-to-action comes at a time when the decades-long effort to end the epidemic in the U.S. is showing overall progress.

Tip Sheet: 4 NCI-Designated Cancer Centers Form AI Alliance, New Database of Hispanic/Latinx Scientists -- and Fred Hutch Volunteer Stories

Fred Hutchinson Cancer Center — Tue, 08 Oct 2024 09:00:15 EST

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.

First Report of Its Kind Describes HIV Reservoir Landscape in Breast Milk

American College of Physicians (ACP) — Mon, 07 Oct 2024 17:00:00 EST

In the first report of its kind, researcher from the University of Buenos Aires evaluated the HIV reservoir in the breast milk cells of two women living with HIV (WLWH) who had been on successful long-term treatment.

Metabolic Risk Factors Among People with HIV Contributed to New-Onset Diabetes Seen in the REPRIEVE Cardiovascular Disease Prevention Trial

American College of Physicians (ACP) — Mon, 07 Oct 2024 17:00:00 EST

An analysis of data from the REPRIEVE statin trial found that metabolic risk factors strongly contributed to the increased cases of new-onset diabetes among people with HIV (PWH).

Study Finds Telehealth Effective for HIV Patients

Rutgers University-New Brunswick — Mon, 07 Oct 2024 15:05:42 EST

Essex County data show that HIV patients maintained their health with remote care during the COVID-19 pandemic.

How Women Can Reduce HIV Risk

Rutgers University-New Brunswick — Mon, 07 Oct 2024 13:05:28 EST

Experts at the Francois-Xavier Bagnoud Center at the Rutgers School of Nursing discuss how PrEP medication can help lower HIV infections

"We Can Reverse Latino HIV Crisis," Guilamo-Ramos

Johns Hopkins School of Nursing — Tue, 24 Sep 2024 13:05:49 EST

Prof. Vincent Guilamo-Ramos, PhD RN Executive Director of the Institute for Policy Solutions (IPS) at Johns Hopkins School of Nursing, joined a diverse group of leaders at the White House today to shine the spotlight on the largely invisible HIV crisis in the Latino community.

Searching for a Vaccine Against an Ancient Scourge

University of North Carolina School of Medicine — Mon, 23 Sep 2024 12:05:54 EST

With data from extensive genomic surveys of the syphilis bacterium - correlated with clinical information from patients - an international team of researchers and doctors are on the hunt for proteins on the surface of the microbe that don't vary and could be good targets for a much-needed vaccine

Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential

Wistar Institute — Tue, 17 Sep 2024 14:05:21 EST

Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.

Bringing Research to the Forefront

University of Miami — Fri, 13 Sep 2024 09:05:59 EST

Dr. Maria Alcaide started her career at the University as an infectious disease physician and has since built a strong research portfolio. She was tapped to be the interim vice provost for research and scholarship.

An Antidiabetic Helps the Immune System Recognize Reservoirs of HIV

Universite de Montreal — Thu, 12 Sep 2024 10:05:20 EST

Researchers at Universite de Montreal's teaching hospital say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.

Triple Antibody Therapy Shows Promise for Long-Lasting HIV Control

Beth Israel Lahey Health — Thu, 12 Sep 2024 09:05:26 EST

In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.

Rutgers Inventors Receive Edison Patent Awards in Industrial Processes, Medical Diagnostics Categories

Rutgers University's Office for Research — Fri, 06 Sep 2024 16:05:29 EST

A catalyst that converts waste CO₂ to chemical products. A monoclonal antibody that could revolutionize the detection of tuberculosis. Both innovations were developed at rutgers, The State University of New Jersey, and both have received 2024 Edison Patent Awards.